Reintroduction of Imatinib in GIST

PURPOSE: This review examines the clinical evidence showing that imatinib can be prescribed to treat recurrence or progression of gastrointestinal stromal tumors (GIST) in patients who interrupted first-line imatinib therapy in the adjuvant or advanced/metastatic setting. METHODOLOGY: A literature s...

Descripción completa

Detalles Bibliográficos
Autor principal: Reid, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825279/
https://www.ncbi.nlm.nih.gov/pubmed/23921604
http://dx.doi.org/10.1007/s12029-013-9532-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825279/
https://www.ncbi.nlm.nih.gov/pubmed/23921604
http://dx.doi.org/10.1007/s12029-013-9532-4

Ejemplares similares